Exact Sciences (EXAS) Stock Highlights

69.48 | +6.01%

2024-09-16 20:06:54

Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exacts Cologuard screening test, a non-invasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a genetic-based treatment selection test for breast, prostate, and colon cancers. With the acquisitions of Base Genomics and Thrive Earlier Detection, Exact is building a multi-cancer early screening test to detect over 14 cancers, a test that would be one of the earliest entrants in multi-cancer liquid biopsy cancer screening.

Statistics

Range Today

66.65 69.75

Volume Today 5.33M

Range 1 Year

40.62 79.62

Volume 1 Year 586.43M

Range 3 Year

29.27 108.99

Volume 3 Year 1.6B

Range 10 Year

4.67 159.54

Volume 10 Year 5.53B

Highlights

Market Capitalization 12.11B (large)

Floating Shares 183.44M

Current Price 69.48

Price To Earnings -69.93

Price To Revenue 5.47

Price To Book 3.79

Earnings Per Share -0.95

Payout Ratio 0%

Performance

Latest +6.01%

1 Month +19.12%

3 Months +68.19%

6 Months +19.36%

1 Year -8.63%

3 Years -32.9%

5 Years -34.35%

10 Years +255.94%

Benchmarks

Market Capitalization

16 / 58

Gross Profits

14 / 52

Total Revenue

16 / 57

Total Rank

43 / 58

Free Cashflow

27 / 56

Performance 5 years

35 / 58

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.